Evidence map›Paper›PMID 37587873›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2023

Design, synthesis and evaluation of dihydro-1

Shengtao Xu, Yijun Sun, Peng Wang, Yuchen Tan, Lei Shi, Jian Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shengtao XuDepartment of Hepatobiliary Surgery, China Medical University, The First People's Hospital of Kunshan, Suzhou, P. R. China.
Yijun SunJiangsu KeyGEN BioTECH Co., Ltd, Nanjing, P. R. China.
Peng WangDepartment of Neurosurgery, China Medical University, The First People's Hospital of Kunshan, Suzhou, Jiangsu, P. R. China.
Yuchen TanDepartment of Medicinal Chemistry, China Pharmaceutical University, Nanjing, P. R. China.
Lei ShiDepartment of Neurosurgery, China Medical University, The First People's Hospital of Kunshan, Suzhou, Jiangsu, P. R. China.
Jian ChenDepartment of Hepatobiliary Surgery, China Medical University, The First People's Hospital of Kunshan, Suzhou, P. R. China.ORCID 0000-0002-7137-7564
Jiangsu University · CNChina Pharmaceutical University · CNViva Biotech (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis plays an important role in tumour generation and progression, which is used to supply nutrients and metastasis. Herein, a series of novel dihydro-1

Indexed as

IndenesTubulin ModulatorsColchicineTubulinColchicineindeneIndenesTubulinTubulin ModulatorsangiogenesisAnticancercolchicine binding siteindenetubulin

Identifiers

PMID37587873
PMCPMC10438863
OpenAlexW4385897957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.